A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
Ronald van Vollenhoven(Amsterdam University Medical Centers), Murray B. Urowitz(Toronto Western Hospital), N. Györi(Karolinska University Hospital), Jamil Missaykeh, Marta Mosca(University of Pisa), Cynthia Aranow(Feinstein Institute for Medical Research), Cindy Coney(Lupus Foundation of America), Ann E. Clarke(University of Calgary), Sandra Navarra(University of Santo Tomas), W. Graninger(Medical University of Graz), Anisur Rahman(University College London), Dimitrios T. Boumpas(National and Kapodistrian University of Athens), Alexandre E. Voskuyl(Amsterdam Neuroscience), Frédéric Houssiau(Cliniques Universitaires Saint-Luc), George Βertsias(University Hospital of Heraklion), Petra Balážová(Institute for Labour and Family Research), Eric F. Morand(Novartis (Switzerland)), Véronique Le Guern(Délégation Paris 5), Ricard Cervera(Hospital Clínic de Barcelona), Caroline Gordon(University of Birmingham), Ian N Bruce(University of Manchester), Andrea Doria(University of Padua), Xavier Mariette(Inserm), Francinne Machado-Ribeiro(Universidade do Estado do Rio de Janeiro), N. Costedoat‐Chalumeau(Délégation Paris 5), Eloísa Bonfá(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Hendrika Bootsma(University Medical Center Groningen), David Isenberg(Regenerative Medicine Institute), Jozef Rovenský(National Institute of Rheumatic Diseases), David Jayne(University of Cambridge), Roger A. Levy(Universidade do Estado do Rio de Janeiro), Anǵela Tincani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Laurent Arnaud(Université Libre de Bruxelles), Kirsten Lerstrøm, Michelle Petri(Johns Hopkins University), Anca Askanase(Columbia University Irving Medical Center), Ruth Fritsch‐Stork(University Medical Center Utrecht), Murat İnanç(Istanbul University), Søren Jacobsen(University of Copenhagen), Thomas Dörner(German Rheumatism Research Centre), Martin Aringer(University Hospital Carl Gustav Carus), Annegret Kuhn(University of Passau), Yehuda Shoenfeld(Tel Aviv University), Ronald H. W. M. Derksen(University Medical Center Utrecht), Ole Petter Rekvig(UiT The Arctic University of Norway), László Czirják(University of Pecs), Josef S Smolen(Leiden University Medical Center), Marzena Olesińska(National Institute of Geriatrics, Rheumatology and Rehabilitation), Irmgard Neumann(Wilhelminen Hospital), Rebecca Fischer‐Betz(Düsseldorf University Hospital)
Cited by 355
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|2k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|1.5k